Cargando…
Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees
We define an iterative method for dimensionality reduction using categorical gradient boosted trees and Shapley values and created four machine learning models which potentially could be used as diagnostic tests for acute myeloid leukaemia (AML). For the final Catboost model we use a dataset of 2177...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582309/ https://www.ncbi.nlm.nih.gov/pubmed/37860531 http://dx.doi.org/10.1016/j.heliyon.2023.e20530 |
_version_ | 1785122301262430208 |
---|---|
author | Angelakis, Athanasios Soulioti, Ioanna Filippakis, Michael |
author_facet | Angelakis, Athanasios Soulioti, Ioanna Filippakis, Michael |
author_sort | Angelakis, Athanasios |
collection | PubMed |
description | We define an iterative method for dimensionality reduction using categorical gradient boosted trees and Shapley values and created four machine learning models which potentially could be used as diagnostic tests for acute myeloid leukaemia (AML). For the final Catboost model we use a dataset of 2177 individuals using as features 16 probe sets and the age in order to classify if someone has AML or is healthy. The dataset is multicentric and consists of data from 27 organizations, 25 cities, 15 countries and 4 continents. The performance of our last model is specificity: 0.9909, sensitivity: 0.9985, F1-score: 0.9976 and its ROC-AUC: 0.9962 using ten fold cross validation. On an inference dataset the perormance is: specificity: 0.9909, sensitivity: 0.9969, F1-score: 0.9969 and its ROC-AUC: 0.9939. To the best of our knowledge the performance of our model is the best one in the literature, as regards the diagnosis of AML using similar or not data. Moreover, there has not been any bibliographic reference which associates AML or any other type of cancer with the 16 probe sets we used as features in our final model. |
format | Online Article Text |
id | pubmed-10582309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105823092023-10-19 Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees Angelakis, Athanasios Soulioti, Ioanna Filippakis, Michael Heliyon Research Article We define an iterative method for dimensionality reduction using categorical gradient boosted trees and Shapley values and created four machine learning models which potentially could be used as diagnostic tests for acute myeloid leukaemia (AML). For the final Catboost model we use a dataset of 2177 individuals using as features 16 probe sets and the age in order to classify if someone has AML or is healthy. The dataset is multicentric and consists of data from 27 organizations, 25 cities, 15 countries and 4 continents. The performance of our last model is specificity: 0.9909, sensitivity: 0.9985, F1-score: 0.9976 and its ROC-AUC: 0.9962 using ten fold cross validation. On an inference dataset the perormance is: specificity: 0.9909, sensitivity: 0.9969, F1-score: 0.9969 and its ROC-AUC: 0.9939. To the best of our knowledge the performance of our model is the best one in the literature, as regards the diagnosis of AML using similar or not data. Moreover, there has not been any bibliographic reference which associates AML or any other type of cancer with the 16 probe sets we used as features in our final model. Elsevier 2023-10-04 /pmc/articles/PMC10582309/ /pubmed/37860531 http://dx.doi.org/10.1016/j.heliyon.2023.e20530 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Angelakis, Athanasios Soulioti, Ioanna Filippakis, Michael Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title | Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title_full | Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title_fullStr | Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title_full_unstemmed | Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title_short | Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
title_sort | diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582309/ https://www.ncbi.nlm.nih.gov/pubmed/37860531 http://dx.doi.org/10.1016/j.heliyon.2023.e20530 |
work_keys_str_mv | AT angelakisathanasios diagnosisofacutemyeloidleukaemiaonmicroarraygeneexpressiondatausingcategoricalgradientboostedtrees AT souliotiioanna diagnosisofacutemyeloidleukaemiaonmicroarraygeneexpressiondatausingcategoricalgradientboostedtrees AT filippakismichael diagnosisofacutemyeloidleukaemiaonmicroarraygeneexpressiondatausingcategoricalgradientboostedtrees |